Recent Management of Patients with Advanced Epidermal Growth Factor Receptor Mutation Non-small Cell Lung Cancer: Role of Afatinib and Lesson Learned for Developing Countries
Lung cancer is a devastating disease with a high incidence, mortality and morbidity rate, especially in developing countries. Conventional treatment with cytotoxic chemotherapy has some limitations attributed to chemoresistance and toxicity. Recent advances have shown that first generation Tyrosine...
Saved in:
Main Authors: | Zulkifli Amin (Author), Vito Filbert Jayalie (Author), Wulyo Rajabto (Author) |
---|---|
Format: | Book |
Published: |
Interna Publishing,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
by: Naoyuki Nishiya, et al.
Published: (2019) -
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O'Leary, et al.
Published: (2020) -
Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection
by: Saumya Shukla, et al.
Published: (2022) -
Evaluation of Epidermal Growth Factor Receptor Gene Mutations in an Iranian Population with Non-Small Cell Lung Carcinoma
by: Hamzeh Salmani, et al.
Published: (2022) -
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020)